Can radiotherapy dose distribution be related to outcome? An analysis of the SCOPE 1 oesophageal cancer trial data

被引：0
|
作者：
Carrington, R. [1 ]
Spezi, E. [2 ]
Gwynne, S. [3 ]
Dutton, P. [4 ]
Hurt, C. [4 ]
Crosby, T. [5 ]
Staffurth, J. [5 ]
机构：
[1] Cardiff Univ, Sch Med, Cardiff, Wales
[2] Velindre Canc Ctr, Med Phys, Cardiff, Wales
[3] Singleton Hosp, Dept Oncol, Swansea, W Glam, Wales
[4] Cardiff Univ, Wales Canc Trials Unit, Cardiff, Wales
[5] Velindre Canc Ctr, Oncol, Cardiff, Wales
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0986
引用
收藏
页码：S526 / S527
页数：2
相关论文
共 50 条
  • [31] A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: Analysis of chronic toxicity
    Brabbins, D
    Martinez, A
    Yan, D
    Lockman, D
    Wallace, M
    Gustafson, G
    Chen, P
    Vicini, F
    Wong, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02): : 400 - 408
  • [32] Prostate cancer dose-response, fractionation sensitivity and repopulation parameters evaluation from 25 international radiotherapy outcome data sets
    Tamponi, Matteo
    Gabriele, Domenico
    Maggio, Angelo
    Stasi, Michele
    Melon, Giovanni B.
    Conti, Maurizio
    Gabriele, Pietro
    BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1098):
  • [33] Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
    T Crosby
    C N Hurt
    S Falk
    S Gollins
    J Staffurth
    R Ray
    J A Bridgewater
    J I Geh
    D Cunningham
    J Blazeby
    R Roy
    T Maughan
    G Griffiths
    S Mukherjee
    British Journal of Cancer, 2017, 116 : 709 - 716
  • [34] Intraoperative radiotherapy for locally advanced prostate cancer: Treatment technique and ultra sound-based analysis of dose distribution
    Orecchia, Roberto
    Jereczek-Fossa, Barbara A.
    Ciocca, Mario
    Vavassori, Andrea
    Cambria, Raffaella
    Cattani, Federica
    Zerini, Dario
    Matei, Deliu V.
    Rocco, Bernardo
    Verweij, Fabrizio
    Scardino, Epifanio
    De Cobelli, Ottavio
    ANTICANCER RESEARCH, 2007, 27 (5B) : 3471 - 3476
  • [35] Analysis of the distribution of dose delivery during respiratory-gated step-and-shoot IMRT for lung cancer radiotherapy
    Xhaferllari, I.
    El-Sherif, O.
    Gaede, S.
    MEDICAL PHYSICS, 2012, 39 (07) : 4634 - 4635
  • [36] Optimal unified combination rule in application of Dempster-Shafer theory to lung cancer radiotherapy dose response outcome analysis
    He, Yanyan
    Hussaini, M. Yousuff
    Gong, Yutao U. T.
    Xiao, Ying
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (01): : 4 - 11
  • [37] The clinical outcome correlations between radiation dose and pretreatment metabolic tumor volume for radiotherapy in head and neck cancer: A retrospective analysis
    Yang, Shih-Neng
    Chiou, Yu-Rou
    Zhang, Geoffrey G.
    Chou, Kuei-Ting
    Huang, Tzung-Chi
    MEDICINE, 2017, 96 (26)
  • [38] OUTCOME AND ANALYSIS OF PROGNOSTIC FACTORS FOR COMBINED RADIOTHERAPY AND HYPERTHERMIA FOR LOCALLY ADVANCED CERVICAL CANCER: DOES A THERMAL DOSE EFFECT EXIST?
    Franckena, M.
    Canters, R.
    Fatehi, D.
    Mens, J. W.
    Lutgens, L.
    van Rhoon, G.
    van der Zee, J.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S244 - S245
  • [39] Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors
    Borm, Kai J.
    Loos, Maximilian
    Oechsner, Markus
    Mayinger, Michael C.
    Paepke, Daniela
    Kiechle, Marion B.
    Combs, Stephanie E.
    Duma, Marciana N.
    RADIATION ONCOLOGY, 2018, 13
  • [40] Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors
    Kai J. Borm
    Maximilian Loos
    Markus Oechsner
    Michael C. Mayinger
    Daniela Paepke
    Marion B. Kiechle
    Stephanie E. Combs
    Marciana N. Duma
    Radiation Oncology, 13
12345